Articles médicaux

Articles médicaux - 2016

Écrit par Paul Coppo

ARTICLES EN FRANÇAIS

[Telemedicine in thrombotic microangiopathies: A way forward in rare diseases requiring emergency care]. Coppo P, Corre E, Rondeau E, Benhamou Y, Bachet A, Stépanian A, Veyradier A; Centre de référence des microangiopathies thrombotiques. Rev Med Interne. 2016 Aug;37(8):514-20.

[Thrombotic thrombocytopenic purpura in a newborn]. hariani I, Jmili-Braham N, Azzebi O, Kortas M, Veyradier A, Bakir L. Arch Pediatr. 2016 Jan;23(1):78-81.

ARTICLES EN ANGLAIS

Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe forms. Coppo P; French Reference Center for Thrombotic Microangiopathies. Transfus Apher Sci. 2016 Dec 30. pii: S1473-0502(16)30205-1.

Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura. Le Besnerais M, Favre J, Denis CV, Mulder P, Martinet J, Nicol L, Levesque H, Veyradier A, Kopić A, Motto DG, Coppo P, Richard V, Benhamou Y. J Thromb Haemost. 2016 Oct;14(10):1917-1930.

Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Joly BS, Stepanian A, Leblanc T, Hajage D, Chambost H, Harambat J, Fouyssac F, Guigonis V, Leverger G, Ulinski T, Kwon T, Loirat C, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Lancet Haematol. 2016 Nov;3(11):e537-e546.

Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study. Benhamou Y, Paintaud G, Azoulay E, Poullin P, Galicier L, Desvignes C, Baudel JL, Peltier J, Mira JP, Pène F, Presne C, Saheb S, Deligny C, Rousseau A, Féger F, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies. Am J Hematol. 2016 Dec;91(12):1246-1251.

Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Soucemarianadin M, Benhamou Y, Delmas Y, Pichereau C, Maury E, Pène F, Halimi JM, Presne C, Thouret JM, Veyradier A, Coppo P. Eur J Haematol. 2016 Aug;97(2):183-91.

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors. Martino S, Jamme M, Deligny C, Busson M, Loiseau P, Azoulay E, Galicier L, Pène F, Provôt F, Dossier A, Saheb S, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies. PLoS One. 2016 Jul 6;11(7):e0156679.

Autoimmune thrombotic thrombocytopenic purpura associated with HHV8-related Multicentric Castleman disease. London J, Boutboul D, Agbalika F, Coppo P, Veyradier A, Gérard L, Oksenhendler E, Azoulay E, Galicier L. Br J Haematol. 2016 May 25.

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Lancet Haematol. 2016 May;3(5):e237-45.

The European Hematology Association Roadmap for European Hematology Research: a consensus document. Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ; EHA Roadmap for European Hematology Research. Haematologica. 2016 Feb;101(2):115-208.

Mis à jour le 14 Février 2022

Articles [9]